Posted on 12/14/20
Arvinas Announces Proposed Offering of Common Stock
NEW HAVEN, Conn., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted . . .
Posted on 12/14/20
Rocket Pharmaceuticals Closes Public Offering
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the . . .
Posted on 12/14/20
Seelos Therapeutics Raises $10 Million
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases
Posted on 12/14/20
Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update
BASKING RIDGE, N.J., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 12/14/20
TG Therapeutics Proposed Public Offering of Common Stock
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases, . . .
Posted on 12/14/20
Better Coronavirus Stock: Johnson & Johnson vs. Pfizer
Big problems tend to attract big problem solvers. So when a global pandemic first threatened the world earlier this year, it wasn't surprising that the two . . .
Posted on 12/14/20
FDA Authorizes Pfizer and BioNTech's Coronavirus Vaccine
Reviewers at the Food and Drug Administration (FDA) are working overtime these days. On Friday, the agency issued a late-evening emergency use authorization for Pfizer (NYSE:PFE) . . .
Posted on 12/13/20
HOOKIPA Pharma Closes Public Offering of $80.9M of Common Stock
NEW YORK and VIENNA, Austria, Dec. 11, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on . . .
Posted on 12/11/20
MetLife Authorized $3 Billion Share Repurchase
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its . . .
Posted on 12/11/20
MetLife to Sell Auto & Home Business to Zurich Insurance Group Subsidiary Farmers Group for $3.94 Billion
MetLife, Inc. (NYSE: MET) today announced that it has signed a definitive agreement to sell Metropolitan Property and Casualty Insurance Company
Posted on 12/11/20
Akari Therapeutics Reports Third Quarter 2020 Financial Results
NEW YORK and LONDON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan . . .
Posted on 12/11/20
3 Reasons to Buy Pfizer Stock Now
The perception of a company can often be overwhelmed by the success of a single one of its products. Investors counting the tens of millions of . . .
Posted on 12/11/20
What Could Keep the FDA From Green Lighting Pfizer's and Moderna's Vaccines?
Pfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) await critical FDA advisory committee reviews for their respective COVID-19 vaccine candidates over the next two weeks. The prospects that both vaccines win . . .
Posted on 12/11/20
FDA Advisory Committee Recommends Emergency Authorization for Pfizer's COVID Vaccine
An advisory committee to the U.S. Food and Drug Administration (FDA) voted late on Thursday to recommend that emergency use authorization (EUA) be given to Pfizer's . . .
Posted on 12/10/20
Cityblock Health Raises $160M Series C
Cityblock Health, a healthcare provider for lower-income communities, announced today the completion of a $160 million Series C funding round and a valuation of over $1 . . .
Posted on 12/10/20
Rocket Pharmaceuticals Prices Upsized Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the . . .
Posted on 12/10/20
Cityblock Health Raises $160M in Series C Funding
Cityblock Health, a Brooklyn, N.Y.-based healthcare provider for lower-income communities, closed a $160m in Series C funding round at a valuation of over $1 billion.
Posted on 12/10/20
Gilead Sciences to Buy MYR GmbH for $1.15 Billion
Gilead Sciences, Inc. (Nasdaq: GILD) acquired MYR GmbH, a Bad Homburg, Germany-based biotechnology company focused on the development and commercialization of therapeutics
Posted on 12/10/20
Cities That Need the Most Initial Vaccinations Against COVID-19 – WalletHub Study
With frontline health care workers and other vulnerable populations like the elderly first in line to receive COVID-19 vaccinations, WalletHub today released its report on the . . .
Posted on 12/10/20
Here's What Could Make Moderna's COVID Vaccine a Bigger Winner Than Pfizer's
We could be only days away from the first two emergency use authorizations (EUA) for COVID-19 vaccines in the U.S. An FDA advisory committee meets on . . .
Posted on 12/10/20
After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?
Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) are heading for the finish line in the coronavirus vaccine race. The U.S. Food and Drug Administration will meet with advisory . . .
Posted on 12/10/20
Is Johnson & Johnson a Great Dividend Stock?
A seemingly "boring" product line up can often make a company a great investment. Think about how many mundane things like shampoo or skin moisturizer you . . .
Posted on 12/10/20
Could Pfizer Be a Millionaire-Maker Stock?
In the past month, Pfizer (NYSE:PFE) stock is up over 20% on the enthusiasm that it will be the first company in the world to bring . . .
Posted on 12/9/20
Rocket Pharmaceuticals Proposes Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces that . . .
Posted on 12/9/20
Conversion Labs Approved for Nasdaq Capital Market Listing
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received approval to uplist to the . . .
New York
